introduction
Oral squamous cell carcinoma (OSCC) is the most common malignant tumor of oral cavity, it is account for 80-90% of all malignancies in oral cavity and the mortality rate remains high about 5% in worldwide and 2,4%-3,57% in Indonesia. 2 Up to now, The molecular pathogenesis of OSCC is still unknown and the diagnosis is only based on clinicopathological examination. Consequently, the most frequent OSCC cases are found in advanced state approximately 76,3%, therefore, the management of OSCC has not shown any satisfactory outcome. 1, 2 Disruption of the cell cycle as well as component regulatory genes which involved in controlling cell cycle is the main factor in the development process of all malignancies, p53 tumor suppressor gene has an important role in malignancy development process especially in early phase of cell cycle G1-S and loss of function p53 gene most common cause of OSCC. 3 Futhermore, p53 gene has shown a direct in activation and has an essential role to control and to regulate cell cycle as well as to induce apoptosis. 4, 5 Subsequently, inactivation of p53 gene would cause the activity of p53 to be disrupted resulting in uncontrolled cell proliferation and if it continuously occurs as a result it could contribute malignancy in all cancers. The aim of this study was to determine the molecular pathogenesis of OSCC and by detecting the presence of p53 mutation in OSCC and to deserve the association of mutation with histopathological grade. The advantage of this study is expected to be able to support clinical diagnosis and histopathological of OSCC consequently the patient could be treated better.
material and methods
In this study, analytical observational comparative study by cross sectional design was used. The subjects of observation were patients who clinically diagnosed as suspected having OSCC, patients who underwent histhopatological diagnosis suffering form OSCC and normal patients who fulfilled the observation's requirement. Furthermore, patients were classified into two groups consisted of well differentiated OSCC and poorly differentiated OSCC and controlled group with normal tissue taken from impacted third molar was taken with surgery indication.
Detection of p53 gene mutation on 40 samples freshed tissue with HPA diagnostic as well and poorly differentiated OSCC and controlled group with normal tissue using PCR-SSCP with primer design p53 of exon 5 and 7 (gene bank accession number U 94788) as follows : exon 5 1 : 5' -TGT TCA CTT GTG GTG CCC TGA CT-3', 5'-AGC AAT CAG TGA GGA ATC AG-3' and exon 5 2 -CAG CCC TGT CGT CTC TCC TTC CT-3', 5'-CAG CCC TGT CGT CTC TCC AG-3' while exon 7 1 : 5'-CTT GCC ACA GGT CTC CCC AA-3', 5'-AGG GGT CAG CGG CAA GA-3' and exon 7 2 : 5'-AGG CGC ACT GGC CTC ATC TT-3', 5'-TGT GCA GGG TGG CAA GTG GC-3'. Next, DNA isolation was performed using procedure of modification DNA isolation by taking biopsy tissue OSCC and normal tissue (1 × 1 × 1 cm) with scalple and washed with PBS solution in eppendorf tubes, added with 700 µl buffer consisted of 50 mM Tris HCl pH 8, 100 mM eDTA, 100 mM NaCl, 1% SDS, 50 ml of 10-20 mg/ml proteinase -K and incubated at 55 °C overnight until cell suspension was achieved. The DNA was extracted from OSCC tissue and controlled tissue using 0,5 ml phenol/CIAA and put into eppendorf shaker (eppendorf mixer 5432) for 2 hours. It was centrifuged for 5 minutes and cell suspension was put into fresh eppendorf tube and transferred into another tube added with 500 ml isopropanol/ethanol until precipitated from was obtained then, the supernatant was disposed. The next step, 500 ml Te buffer was added into cell suspension in eppendorf tube and incubated overnight at room temperature. Afterward, eppendorf tube was shaken manually until it was well mixed. DNA identification was done using 2% agarose gel electrophoresis and visualized by UV light. DNA concentration test was done by spectrophotometry. 6 SSCP analysis for DNA resulted from p53 gene PCR product (exon 5.7). 40 samples were divided in which every group consisting of 10 samples then, 5 ml DNA of PCR resulted from optimal product of p53 gene PCR, every group was marked with number of samples and K for control group. Next step, 10 ml formamid was added as loading buffer, 15 ml denaturation solution was achieved in eppendorf, shaken eppendorf with vertical rotater was done followed by centrifuged. Denaturation was continued in boiling water at 100 °C for 10 minutes, and chilled using nitrogen liquid at -80 °C for 5-10 minutes. each PCR tube contained 15 µl of DNA p53 gene was added with buffer loading, followed by analysis using 12% non denaturation acrylamide gel electrophoresis at room temperature for 5 hours with constant voltage 150 °C. Furthermore, silver nitrate staining was done with following procedure; fixer solution (7.5% acetic acid) for 30 min and washed (3×) using dionized water (dH 2 O) for 10 minutes. Then added with 100ml silver nitrate solution (1.5 g/l AgNO 3 and 0.056% formaldehyde) for 45 minutes and rinsed with dionized water for 15 seconds. Furthermore, image development was done with developer solution 30 g/l Na 2 CO 3 , 0,056% formaldehyde 2 mg/l sodium thiosulfate for 2-5 min. Stop solution with fixer solution 7,5% acid at (-4 °C) for 30 seconds until 5 min. The result of SSCP analysis the product of p53 gene PCR exon 5 and 7 showed the migration pattern or single stranded conformation polymorphism (SSCP) could exhibit 2 bands in unsimilar position with 2 band of DNA resulted from controlled SSCP showed the presence of homezygote mutation. Indicating positive (+) or positive mutation (score 1), if the result was 3 bands or 4 bands of DNA p53 gene exon 5.7 unsimilar position with 2 bands of normal DNA SSCP (controlled PCR-SSCP) showed the presence of heterozygote mutation indicating positive (+) or score 1, if the result was 2 bands in p53 exon 5.7 in similar position with 2 bands in controlled PCR-SSCP indicating the absence of mutation negative (-) or score 0. 6 Cross sectional data analysis was done using SPSS program version 11. The data resulting from observation of gene mutation by PCR-SSCP method in all samples was useful to know the absence or the presence of GST p53 gene mutation (exon 5.7) and the correlation with HPA data: well and poorly differentiated OSCC. The contingency coefficient test was used for statically analysis to know the strength and the weakness of HPA correlation: well or poorly differentiated OSCC with tumor suppressor p53 gene mutation resulted from p53 gene mutation exon 5.7 in OSCC. The result of statistical test of the association of histophatological feature between well poorly differentiated of p53 exon 7 of OSCC, no significant association with value 0.100 and p = 0.525 between well and poorly differentiated p53 exon 7, shown on table 4.
discussion
The incidence of p53 mutation over 50% was frequently found in exon 5-8 in all cancers especially exon 5 and 7 for colorectal and laryngeal carcinoma. 7, 8 In this study the incidence of p53 mutation in OSCC has shown 28/40 (70%), exon 7; 22/40 (55%) and exon 5; 11/40 (27.5%). The result indicated that mutation of gene p53 more frequently involved in molecular control of OSCC cell cycle and it is not influenced by alteration of other tumor suppressor gene inactivation in OSCC cell cycle. Seventy percent of p53 mutation showed that p53 gene has controlling function of cell cycle and encountered 70% inactivation or loss stability of p53 function as factor of transcription gene p21 Walf1/Cip1, MDM2, GADD45, 14-3-3a Bax and KILLeR/DR5 which has an important role in controlling and regulating cell cycle, improvement of damaged DNA as well as apoptosis. In this case, p53 showed more direct role in G1/S phase, comparing with gene 21 which also has direct activation in G1/S phase, however, further study is necessarily done. The dysregulation of the molecular events governing cell cycle control is emerging as a central theme of oral carcinogenesis. Regulatory pathways responding to extracellular signaling or intra cellular stress and DNA damage converge on the cell cycle apparatus. Abrogation of mitogenic and anti-mitogenic response regulatory proteins, such as the retinoblastoma tumor suppressor protein (pRB), cyclin D1, cyclin-dependent kinase (CDK) 6, and CDK inhibitors (p21(WAF1/CIP1), p27 (KIP1), and p16 (INK4a), occur frequently in human oral cancers. In this study, 30% mutation of p53 gene was not found and probably caused by other gene mechanism such as : gene p21, pRB, p27 and oncogen cyclin D1, CDK6 involving directly in mechanism of cancer cell cycle control especially in G1-S phase of cell. 9 In this study exon 7 (55%) with heterozygous mutation 100% was found higher than exon 5 (27.5%) with homozygous mutation 18,2%. The result of this study also suggested that in OSCC mutation of p53 exon 7 more frequently occurred than exon 5 and mostly involved in molecular pathogenesis of OSCC. Meanwhile, p53 gene exon 5 with 81.8% heterozygous mutation and 18.2% homozygous mutation could induce uncontrolled cell proliferation, therefore p53 exon had an important role in controlling cancer cell cycle. Tumor suppressor gene p53 has the highest heterozygous mutation in exon 7 comparing with the result of study done in foreign country: 22/22 (100%), homozygous mutation 0/22 (0%) and exon 5 with heterozygous mutation 9/11 (81.8%) homozygous mutation 2/11 (18.2%). The result of the study is not equivalent to the outcome of some studies done in foreign countries which suggested p53 with heterozygous mutation 65% in China, 9 heterozygous mutation p53 (exon 2-9) 55% in england, 10 and less frequent heterozygous mutation p53 in India. 11 p53 gene especially exon 7 (55%) with homozygous mutation 100% would induce loss of p53 function in which dominant mutation in one of both alelle of chromosome resulting more uncontrolled cell cycle proliferation as the cause of malignancy in OSCC, Therefore, p53 exon 7 is ideal to be molecular indicator to detect the level of malignancy especially OSCC. Meanwhile, although in p53 exon 5 less possibilities (27.5%) of other genes mechanism was found involved in controlling cell cycle of OSCC, consequently, mutation could occur in the other region of exon 5 or in other hot spot region. Interestingly, in p53 exon 5 with high heterozygous mutation (81.8%) was found and it shows that p53 exon 5 also has essential role in controlling cell cycle of cancer as the cause of OSCC and could be targeted as molecular indicator to detect the level of OSCC malignancy. In this study, no significant association (p = 0.168) was found between well and poorly differentiation OSCC with p53 mutation of exon 7 (55%, p = 0.525), the possibility of other gene mechanism which directly plays an essential role in the mechanism of molecular pathogenesis such as p21 gene which could directly inhibit the activation of excessive cell proliferation in cell cycle. Significant association (p = 0.0013) was found in p53 gene exon 5 (27.5%) with heterozygous mutation 81.8% and homozygous mutation 18.2% in well and poorly differentiated OSCC. This study is not equivalent to the outcome of study done in Germany for head and neck cancer and in china for breast cancer. 12 So the result of this study shows that in tumor suppressor gene p53 exon 5 although the incidence of mutation is relatively small, however, it has an essential role in the progressivity of cancer, it could be shown by the presence of p53 mutation exon 5 in well differentiated OSCC (20%) and the increase of mutation (80%) in poorly differentiated OSCC, therefore, p53 exon 5 is ideal to be an indicator to detect the level of malignancy especially when well differentiated OSCC is found. Therefore, it could be used either as diagnosis indicator or as a molecular prognosis of OSCC.
It could be concluded that detection of p53 mutation of OSCC in oral cancer 70% of total samples was found p53 exon 7 (55%) with heterozygous mutation 100%, therefore, p53 exon 7 is ideal to be targeted indicator of molecular diagnosis and prognosis of OSCC but it is not specific for histopathological feature of well and poorly differentiated OSCC. Meanwhile, p53 exon 5 (27.5%) has significant association in histopathological feature between well and poorly differentiated OSCC (p = 0.013) therefore, p53 exon 5 is ideal to be targeted indicator of molecular diagnosis and prognosis of OSCC especially well differentiated OSCC.
In addition, it is necessary to perform a study on p53 detection using clinical feature parameter such as: age, gender, tumor location, tumor staging, TNM System and sequencing procedure is done to detect the type and location af DNA mutation so, it would be useful to increase and to confirm the outcome of this study such as: performing a study on other tumor suppressor gene which frequently involving in the mechanism of molecular pathogenesis of cell cycle such as : p21, pRB, p27, and other oncogene: cyclin D1, CdK4, e2F, MDM2 and c-myc so it would be useful to elucidate molecular pathogenesis of cancer especially OSCC.
